Loading
Latest filing published 03 Jun 2011 for Talecris Biotherapeutics Holdings Corp..
No signal scores available.
James R. Engle is a declared insider of Talecris Biotherapeutics Holdings Corp., with filings sourced from SEC (Form 4). Between 30 September 2009 and 1 June 2011, the trades on record add up to 12 filings.
The open-market record consists of 4 sales worth €1.6M, with no purchase. Other entries cover 4 share grants and 3 option exercises.
The record was last updated on 3 June 2011 with a transaction in Talecris Biotherapeutics Holdings Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations